A novel new therapy to treat type 2 diabetes that lowers blood sugar, decreases insulin resistance, lowers cholesterol and helps keep fatty deposits from settling in the liver is in the works at Columbia University Medical Center, and researchers hope to eventually test it on humans. So far, studies on mice show promising results with no side effects. The treatment targets the hormone glucagon instead of insulin. Glucagon is a hormone whose main purpose is to protect the body and brain from low blood sugar levels during period of fasting, such as overnight. When certain cells in the pancreas sense ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.